Join
Live feed
·
PRReleasevia Quantisnow
Royalty Pharma plc logo
BioCryst Pharmaceuticals Inc. logo

Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RPRX (Royalty Pharma plc), BCRX (BioCryst Pharmaceuticals Inc.) and more on Quantisnow.